Abstract
Background
Haemorrhagic morbidity is more common in women with abnormal placentation, that is placenta praevia or morbidly adherent placenta. The incidence of abnormal placentation is increasing due to rising caesarean section rates. Concerns regarding blood safety, blood shortages and soaring costs of blood processing have generated growing enthusiasm for blood conservation strategies. The aim of our study was to look at intraoperative cell salvage (IOCS) use and allogeneic transfusion patterns in patients with abnormal placentation.
Methods
Patients with abnormal placentation were identified from the hospital database over a 2-year period between 2015 and 2016. Information collected for those that had IOCS setup included estimated blood loss, volume of blood collected and returned, pre- and postoperative haemoglobin levels and use of allogeneic blood.
Results
A total of 139 cases of abnormal placentation were identified. Abnormal placentation accounted for 62% of all cases of IOCS usage and was established for 53 patients with abnormal placentation. The re-transfusion rate was 18.5%. Five patients received IOCS blood only. The allogeneic transfusion rate was 7.5% in patients who had IOCS setup compared with 6.9% in those who did not (p = 1.00). Median blood loss was greater for patients who had IOCS blood returned compared with patients who had not (p = 0.004). The median volume of blood returned was 520 (114–608) mL. Preoperative haemoglobin levels were lower for patients who received a combination of cell salvage and allogeneic blood (p = 0.006).
Conclusions
IOCS contributed to a reduction or elimination of allogeneic transfusion for a proportion of this high-risk cohort and should be an integral component of a hospitals’ blood conservation strategy.
Similar content being viewed by others
References
Knight M NM, Tuffnell D, Shakespeare J, Kenyon S, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. (2017) Saving lives, improving mothers’ care - lessons learned to inform maternity care from the UK and Ireland Con dential Enquiries into Maternal Deaths and Morbidity 2013–15. Oxford: National Perinatal Epidemiology Unit, University of Oxford
Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Collins S, Dornan S, Jurkovic D, Kayem G, Kingdom J, Silver R, Sentilhes L Placenta praevia and placenta accreta: diagnosis and management. BJOG Int J Obstet Gynaecol. https://doi.org/10.1111/1471-0528.15306
Creanga AA, Bateman BT, Butwick AJ, Raleigh L, Maeda A, Kuklina E, Callaghan WM (2015) Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol 213(3):384.e381–384.e311. https://doi.org/10.1016/j.ajog.2015.05.002
O'Brien JM, Barton JR, Donaldson ES (1996) The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 175(6):1632–1638
Bauer ST, Bonanno C (2009) Abnormal placentation. Semin Perinatol 33(2):88–96. https://doi.org/10.1053/j.semperi.2008.12.003
Mhyre JM, Shilkrut A, Kuklina EV, Callaghan WM, Creanga AA, Kaminsky S, Bateman BT (2013) Massive blood transfusion during hospitalization for delivery in New York state, 1998-2007. Obstet Gynecol 122(6):1288–1294. https://doi.org/10.1097/AOG.0000000000000021
Gibbins KJ, Einerson BD, Varner MW, Silver RM (2017) Placenta previa and maternal hemorrhagic morbidity. J Matern Fetal Neonatal Med:1–17. https://doi.org/10.1080/14767058.2017.1289163
Bateman BT, Mhyre JM, Callaghan WM, Kuklina EV (2012) Peripartum hysterectomy in the United States: nationwide 14 year experience. Am J Obstet Gynecol 206(1):63.e61–63.e68. https://doi.org/10.1016/j.ajog.2011.07.030
Klein AA, Bailey CR, Charlton AJ, Evans E, Guckian-Fisher M, McCrossan R, Nimmo AF, Payne S, Shreeve K, Smith J, Torella F (2018) Association of anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 73(9):1141–1150. https://doi.org/10.1111/anae.14331
American College of Obstetricians and Gynecologists (2002) ACOG committee opinion. Placenta accreta. Number 266, January 2002. Int J Gynaecol Obstet 77(1):77–78
Goucher H, Wong CA, Patel SK, Toledo P (2015) Cell salvage in obstetrics. Anesth Analg 121(2):465–468. https://doi.org/10.1213/ANE.0000000000000786
Marr L, Lennox C, McFadyen AK (2014) Quantifying severe maternal morbidity in Scotland: a continuous audit since 2003. Curr Opin Anaesthesiol 27(3):275–281. https://doi.org/10.1097/aco.0000000000000079
Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J (2009) Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the international postpartum hemorrhage collaborative group. BMC Pregnancy Childbirth 9:55. https://doi.org/10.1186/1471-2393-9-55
Bateman BT, Berman MF, Riley LE, Leffert LR (2010) The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg 110(5):1368–1373. https://doi.org/10.1213/ANE.0b013e3181d74898
Manning ELS, Corcoran P, Mckernan J, de Foubert P, Green RA (2018) Severe maternal morbidity in Ireland annual report 2016. National Perinatal Epidemiology Centre https://www.ucc.ie/en/media/research/nationalperinatalepidemiologycentre/annualreports/SevereMaternalMorbidityinIrelandAnnualReport2016.pdf. Accessed 22 October 2018
White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, Allard S (2016) Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med 26(4):246–263. https://doi.org/10.1111/tme.12299
Cresswell JA, Ronsmans C, Calvert C, Filippi V (2013) Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Tropical Med Int Health 18(6):712–724. https://doi.org/10.1111/tmi.12100
Taylor NJ, Russell R Anaesthesia for abnormally invasive placenta: a single-institution case series. Int J Obstet Anesth. https://doi.org/10.1016/j.ijoa.2017.01.008
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M (2014) The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. Bjog 121(1):62–71. https://doi.org/10.1111/1471-0528.12405
King M, Wrench I, Galimberti A, Spray R (2009) Introduction of cell salvage to a large obstetric unit: the first six months. Int J Obstet Anesth 18(2):111–117. https://doi.org/10.1016/j.ijoa.2008.07.010
Taylor NJ, Russell R (2017) Anaesthesia for abnormally invasive placenta: a single-institution case series. Int J Obstet Anesth 30:10–15. https://doi.org/10.1016/j.ijoa.2017.01.008
National Institute for Health and Clinical Excellence (2012) Intraoperative blood cell salvage in obstetrics. NICE. https://www.nice.org.uk/guidance/ipg144. Accessed 09/05/2018
Khan K, Moore P, Wilson MJ, Hooper R, Allard S, Wrench I, Beresford L, Roberts T, McLoughlin C, Geoghegan J, Daniels JP, Catling S, Clark VA, Ayuk P, Robson S, Gao-Smith F, Hogg M, Lanz D, Dodds J (2017) LB01: cell salvage during caesarean section: a randomised controlled trial (the SALVO trial). Am J Obstet Gynecol 216(1):S559. https://doi.org/10.1016/j.ajog.2016.11.1047
Brearton C, Bhalla A, Mallaiah S, Barclay P (2012) The economic benefits of cell salvage in obstetric haemorrhage. Int J Obstet Anesth 21(4):329–333. https://doi.org/10.1016/j.ijoa.2012.05.003
Esper SA, Waters JH (2011) Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 9(2):139–147. https://doi.org/10.2450/2011.0081-10
Paterson-Brown S, Bamber J, on behalf of the MBRRACE-UK haemorrhage chapter writing group (2014) Prevention and treatment of haemorrhage. Saving lives, improving mothers’ care - lesons learned to inform future maternity care from the UK and Ireland confidential enquires into maternal deaths and morbidity 2009-2012, vol 2014. National Perinatal Epidemiology Unit, University of Oxford, Oxford, pp p45–p55
Liumbruno GM, Liumbruno C, Rafanelli D (2012) Autologous blood in obstetrics: where are we going now? Blood Transfus 10(2):125–147. https://doi.org/10.2450/2011.0010-11
Association of Anaesthetist of Great Britian and Ireland (2009) Blood transfusion and the anaesthetist. Intraoperative cell salvage. https://www.aagbi.org/sites/default/files/cell%20_salvage_2009_amended.pdf. Accessed 18/11/2019
Chesley LC (1972) Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 112(3):440–450
Bonnar J (2000) Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 14(1):1–18
Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S (1998) The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 179(3):715–720
Rainaldi MP, PLT, Scagliarini G, Borghi B, Conte R (1998) Cell salvage during caesarean section. Br J Anaesth 80:195–198
Parry N, Junghans C, Skelton V, Okunuga A (2010) Audit of cell salvage use in obstetric patients: adding experience. Int J Obstet Anesth 19(2):238–239. https://doi.org/10.1016/j.ijoa.2009.09.001
McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ (2010) The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care 38(3):492–499
Bolton-Maggs P PD, Watt A, Thomas D (2018) The annual SHOT report 2018. https://www.shotuk.org/shot-reports/report-summary-and-supplement-2018/. Accessed 12th December 2019
Endean EPS, Sullivan I, Ralph CJ (2017) Routine use of IOCS for caesarean section and its affect on antibody formation. Transfus Med 27(S2):p51
Acknowledgements
We would like to acknowledge Mr. Colin Kirkham, research officer at the Rotunda Hospital for his assistance with the statistical analysis involved in the study.
Contribution to authorship
DOF conceived the idea of this study, contributed to study design, performed data collection, performed the data analysis and interpretation and prepared the manuscript. SE reviewed the study design, contributed to data collection, data analysis and interpretation and review of manuscript. FNA contributed to interpretation of data and revised the manuscript for important intellectual content. NH conceived the idea of the study, contributed significantly to study design, contributed to data extraction and interpretation and preparation of the manuscript including revision for important intellectual content. All authors approved the final version of the manuscript and accept responsibility for the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Approval was obtained from the Rotunda Hospitals’ ethics committee on the 26th January 2016 (reference 16-020).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
O’Flaherty, D., Enright, S., Ainle, F.N. et al. Intraoperative cell salvage as part of a blood conservation strategy in an obstetric population with abnormal placentation at a large Irish tertiary referral centre: an observational study. Ir J Med Sci 189, 1053–1060 (2020). https://doi.org/10.1007/s11845-020-02182-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-020-02182-x